PCOS Weight Loss: Finally Break the Cycle
You've tried dieting. You've tried exercising more. But with PCOS, your body fights back—storing fat instead of burning it. It's not your fault. Insulin resistance is driving your weight gain, and willpower alone can't fix biology. GLP-1 medications like compounded semaglutide can.
Why PCOS Makes Weight Loss So Hard
Understanding the biology behind your struggle is the first step to overcoming it.
Insulin Resistance
Your cells don't respond to insulin properly, causing elevated insulin levels that promote fat storage.
Stubborn Belly Fat
High insulin drives fat storage specifically around your midsection—the hardest fat to lose.
Increased Appetite
Hormonal imbalances increase hunger signals and cravings, especially for carbohydrates.
Slower Metabolism
PCOS affects thyroid function and metabolic rate, meaning you burn fewer calories at rest.
The PCOS-Insulin Connection
Polycystic Ovary Syndrome affects up to 10% of women, and weight gain is one of its most frustrating symptoms. But the real culprit isn't overeating—it's insulin resistance.
When you have PCOS, your cells become less responsive to insulin. Your pancreas compensates by producing more insulin, and those elevated insulin levels tell your body to store fat—especially around your abdomen. This creates a vicious cycle: more fat leads to more insulin resistance, which leads to more fat storage.
Traditional diets fail because they don't address this underlying biology. You can cut calories dramatically and still struggle to lose weight because your hormones are working against you. That's why targeted medical treatment is so effective for PCOS weight loss.
- 70% of women with PCOS have insulin resistance
- PCOS increases diabetes risk 4x compared to other women
- Losing just 5-10% body weight can restore ovulation
- GLP-1 medications directly improve insulin sensitivity
Our Approach to PCOS Weight Loss
We don't just prescribe medication—we understand and treat the whole picture.
Comprehensive Assessment
We start with DEXA body composition analysis, metabolic testing, and comprehensive labs including fasting insulin, glucose, A1C, and hormone panels. This tells us exactly what's happening in your body.
Targeted GLP-1 Therapy
Semaglutide and tirzepatide directly address insulin resistance—the root cause of PCOS weight gain. These medications reduce appetite, improve insulin sensitivity, and help break the cycle that's been holding you back.
Body Composition Tracking
We may use DEXA to estimate changes in fat mass and lean mass so nutrition, resistance training, medication, and follow-up can be reassessed over time.
Physician-Led PCOS Weight Care
PCOS-related weight concerns deserve evaluation without blame or a one-cause explanation. Highland reviews metabolic health, symptoms, medications, nutrition, activity, sleep, reproductive plans, treatment risks, and patient goals before recommending an option.
— Dr. Josh Lindsley, DO, DABOM
PCOS Treatment Options
Options are selected after individualized review; no medication treats every cause of weight change or guarantees a PCOS outcome.
Semaglutide
GLP-1 Receptor AgonistA GLP-1 receptor agonist considered only when the weight-management indication, medical history, contraindications, current medications, reproductive plans, risks, and goals support treatment.
- Semaglutide is not approved specifically for PCOS
- Appetite response and adverse effects monitored
- Approved-product trials do not predict an individual result
- Twice-weekly injection
Tirzepatide
Dual GLP-1/GIP AgonistA medication that acts at GIP and GLP-1 receptors and may be considered only after individualized review of medical history, contraindications, current medicines, reproductive plans, risks, and goals.
- Response and clinically indicated markers monitored over time
- Approved-product trials do not predict an individual result
- Reproductive plans reviewed before treatment
- Twice-weekly injection
DEXA Body Composition
Precision TrackingDEXA estimates fat mass, lean mass, regional distribution, and bone mineral measures; it does not measure muscle directly or guarantee preservation.
- Body-composition estimates interpreted over time
- Estimates regional fat distribution
- Estimates changes in lean mass
- 10-minute scan
Metabolic Testing (RMR)
Know Your NumbersA breath test estimates resting energy expenditure and may help inform nutrition planning alongside the broader evaluation.
- Estimated resting energy expenditure
- Interpreted with clinical context
- Personalized nutrition planning
- 20-minute breath test
PCOS Weight Loss FAQs
No. Highland discusses FDA-approved options first and limits compounding to documented patient-specific needs. We do not dispense Wegovy, Ozempic, Rybelsus, Zepbound, or Mounjaro. Compounded medications are not FDA-approved.
PCOS is heterogeneous. Insulin resistance, sleep, medications, mood, nutrition, activity, reproductive goals, and other health conditions may affect weight differently in each patient. Evaluation should not assume one cause or reduce the problem to willpower.
Semaglutide is not approved specifically to treat PCOS. Whether it is appropriate depends on the weight-management indication, metabolic health, medical history, contraindications, current medications, reproductive plans, risks, access, and goals. Approved-product studies do not establish outcomes for Highland's compounded formulation.
No improvement in menstrual patterns, ovulation, androgen-related symptoms, fertility, or metabolic markers is guaranteed. These outcomes have multiple causes and are monitored separately when clinically relevant.
Highland's primary role on this page is weight-management evaluation. Hormone-related symptoms, metabolic findings, reproductive goals, and existing treatment are reviewed, with gynecology or endocrinology coordination when appropriate.
Semaglutide should not be used during pregnancy. Current product labeling advises stopping semaglutide at least two months before a planned pregnancy. Pregnancy plans and contraception should be reviewed with the prescribing clinician.
Response and timing vary by medication, dose, health conditions, adherence, and patient. Follow-up focuses on tolerability, adverse effects, weight and waist trends, body-composition estimates when useful, and clinically indicated laboratory monitoring; no amount or timeline is guaranteed.
Serving Fort Worth & Surrounding Communities
Our clinic is conveniently located in the Fort Worth Alliance area, just minutes from communities throughout the DFW metroplex.
Located at 4801 Golden Triangle Blvd Suite 121, Fort Worth, TX 76244
Ready for an Individual PCOS Weight Evaluation?
Schedule a consultation to review your history, current treatment, reproductive plans, risks, goals, and evidence-based weight-management options.
Compounded medication disclaimer: Highland discusses FDA-approved options first and limits compounding to documented patient-specific needs. We do not dispense Wegovy®, Ozempic®, Rybelsus®, Zepbound®, or Mounjaro®, which are brand-name products manufactured by Novo Nordisk and Eli Lilly.
Compounded GLP-1 medications are prepared by a state-licensed compounding pharmacy under the supervision of our physician. Compounded medications are not FDA-approved. They are permitted under federal law when an FDA-approved product cannot meet the patient's clinical needs, or when the FDA designates a shortage. Your physician will discuss the implications, risks, and benefits of compounded therapy at your consultation.